These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

769 related items for PubMed ID: 15790433

  • 21. Inhibition of BAD phosphorylation either at serine 112 via extracellular signal-regulated protein kinase cascade or at serine 136 via Akt cascade sensitizes human ovarian cancer cells to cisplatin.
    Hayakawa J, Ohmichi M, Kurachi H, Kanda Y, Hisamoto K, Nishio Y, Adachi K, Tasaka K, Kanzaki T, Murata Y.
    Cancer Res; 2000 Nov 01; 60(21):5988-94. PubMed ID: 11085518
    [Abstract] [Full Text] [Related]

  • 22. Phosphoinositide 3-kinase/Akt involvement in arsenic trioxide resistance of human leukemia cells.
    Tabellini G, Cappellini A, Tazzari PL, Falà F, Billi AM, Manzoli L, Cocco L, Martelli AM.
    J Cell Physiol; 2005 Feb 01; 202(2):623-34. PubMed ID: 15316930
    [Abstract] [Full Text] [Related]

  • 23. AKT and mTOR phosphorylation is frequently detected in ovarian cancer and can be targeted to disrupt ovarian tumor cell growth.
    Altomare DA, Wang HQ, Skele KL, De Rienzo A, Klein-Szanto AJ, Godwin AK, Testa JR.
    Oncogene; 2004 Jul 29; 23(34):5853-7. PubMed ID: 15208673
    [Abstract] [Full Text] [Related]

  • 24. Frequent monoallelic deletion of PTEN and its reciprocal associatioin with PIK3CA amplification in gastric carcinoma.
    Byun DS, Cho K, Ryu BK, Lee MG, Park JI, Chae KS, Kim HJ, Chi SG.
    Int J Cancer; 2003 Apr 10; 104(3):318-27. PubMed ID: 12569555
    [Abstract] [Full Text] [Related]

  • 25. Role of the phosphatidylinositol 3'-kinase/PTEN/Akt kinase pathway in tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in non-small cell lung cancer cells.
    Kandasamy K, Srivastava RK.
    Cancer Res; 2002 Sep 01; 62(17):4929-37. PubMed ID: 12208743
    [Abstract] [Full Text] [Related]

  • 26. PAK4 confers cisplatin resistance in gastric cancer cells via PI3K/Akt- and MEK/ERK-dependent pathways.
    Fu X, Feng J, Zeng D, Ding Y, Yu C, Yang B.
    Biosci Rep; 2014 Apr 01; 34(2):. PubMed ID: 27919028
    [Abstract] [Full Text] [Related]

  • 27. PTEN reverses MDM2-mediated chemotherapy resistance by interacting with p53 in acute lymphoblastic leukemia cells.
    Zhou M, Gu L, Findley HW, Jiang R, Woods WG.
    Cancer Res; 2003 Oct 01; 63(19):6357-62. PubMed ID: 14559824
    [Abstract] [Full Text] [Related]

  • 28. Akt-mediated cisplatin resistance in ovarian cancer: modulation of p53 action on caspase-dependent mitochondrial death pathway.
    Yang X, Fraser M, Moll UM, Basak A, Tsang BK.
    Cancer Res; 2006 Mar 15; 66(6):3126-36. PubMed ID: 16540663
    [Abstract] [Full Text] [Related]

  • 29. Effect of tumor suppressor gene PTEN on the resistance to cisplatin in human ovarian cancer cell lines and related mechanisms.
    Wu H, Cao Y, Weng D, Xing H, Song X, Zhou J, Xu G, Lu Y, Wang S, Ma D.
    Cancer Lett; 2008 Nov 28; 271(2):260-71. PubMed ID: 18657898
    [Abstract] [Full Text] [Related]

  • 30. Association between cisplatin resistance and mutation of p53 gene and reduced bax expression in ovarian carcinoma cell systems.
    Perego P, Giarola M, Righetti SC, Supino R, Caserini C, Delia D, Pierotti MA, Miyashita T, Reed JC, Zunino F.
    Cancer Res; 1996 Feb 01; 56(3):556-62. PubMed ID: 8564971
    [Abstract] [Full Text] [Related]

  • 31. RY-2f, an isoflavone analog, overcomes cisplatin resistance to inhibit ovarian tumorigenesis via targeting the PI3K/AKT/mTOR signaling pathway.
    Liu M, Qi Z, Liu B, Ren Y, Li H, Yang G, Zhang Q.
    Oncotarget; 2015 Sep 22; 6(28):25281-94. PubMed ID: 26325371
    [Abstract] [Full Text] [Related]

  • 32. AKT involvement in cisplatin chemoresistance of human uterine cancer cells.
    Gagnon V, Mathieu I, Sexton E, Leblanc K, Asselin E.
    Gynecol Oncol; 2004 Sep 22; 94(3):785-95. PubMed ID: 15350374
    [Abstract] [Full Text] [Related]

  • 33. PIK3CA alterations in Middle Eastern ovarian cancers.
    Abubaker J, Bavi P, Al-Haqawi W, Jehan Z, Munkarah A, Uddin S, Al-Kuraya KS.
    Mol Cancer; 2009 Jul 28; 8():51. PubMed ID: 19638206
    [Abstract] [Full Text] [Related]

  • 34. PTEN activation contributes to tumor inhibition by trastuzumab, and loss of PTEN predicts trastuzumab resistance in patients.
    Nagata Y, Lan KH, Zhou X, Tan M, Esteva FJ, Sahin AA, Klos KS, Li P, Monia BP, Nguyen NT, Hortobagyi GN, Hung MC, Yu D.
    Cancer Cell; 2004 Aug 28; 6(2):117-27. PubMed ID: 15324695
    [Abstract] [Full Text] [Related]

  • 35. Src family protein-tyrosine kinases alter the function of PTEN to regulate phosphatidylinositol 3-kinase/AKT cascades.
    Lu Y, Yu Q, Liu JH, Zhang J, Wang H, Koul D, McMurray JS, Fang X, Yung WK, Siminovitch KA, Mills GB.
    J Biol Chem; 2003 Oct 10; 278(41):40057-66. PubMed ID: 12869565
    [Abstract] [Full Text] [Related]

  • 36. The inducible expression of the tumor suppressor gene PTEN promotes apoptosis and decreases cell size by inhibiting the PI3K/Akt pathway in Jurkat T cells.
    Xu Z, Stokoe D, Kane LP, Weiss A.
    Cell Growth Differ; 2002 Jul 10; 13(7):285-96. PubMed ID: 12133897
    [Abstract] [Full Text] [Related]

  • 37. Wortmannin enhances cisplatin-induced apoptosis in human ovarian cancer cells in vitro.
    Zhao JX, Liu H, Lv J, Yang XJ.
    Eur Rev Med Pharmacol Sci; 2014 Jul 10; 18(17):2428-34. PubMed ID: 25268086
    [Abstract] [Full Text] [Related]

  • 38. Frequent genetic and biochemical alterations of the PI 3-K/AKT/PTEN pathway in head and neck squamous cell carcinoma.
    Pedrero JM, Carracedo DG, Pinto CM, Zapatero AH, Rodrigo JP, Nieto CS, Gonzalez MV.
    Int J Cancer; 2005 Mar 20; 114(2):242-8. PubMed ID: 15543611
    [Abstract] [Full Text] [Related]

  • 39. Par-4 downregulation confers cisplatin resistance in pancreatic cancer cells via PI3K/Akt pathway-dependent EMT.
    Tan J, You Y, Xu T, Yu P, Wu D, Deng H, Zhang Y, Bie P.
    Toxicol Lett; 2014 Jan 03; 224(1):7-15. PubMed ID: 24144893
    [Abstract] [Full Text] [Related]

  • 40. PTEN augments staurosporine-induced apoptosis in PTEN-null Ishikawa cells by downregulating PI3K/Akt signaling pathway.
    Wan X, Yokoyama Y, Shinohara A, Takahashi Y, Tamaya T.
    Cell Death Differ; 2002 Apr 03; 9(4):414-20. PubMed ID: 11965494
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 39.